View in EDS HTML Full Text PDF Full Text

Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.

Saved in:
Bibliographic Details
Title: Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
Authors: Butt N; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway., Bache-Mathiesen LK, Nordrehaug JE, Tuseth V, Munk PS, Bonarjee V, Hall TS, Jensen SE, Halvorsen S, Firat H, Atar D, Larsen AI
Source: Cardiology [Cardiology] 2017; Vol. 138 (2), pp. 122-132. Date of Electronic Publication: 2017 Jun 27.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 1266406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9751 (Electronic) Linking ISSN: 00086312 NLM ISO Abbreviation: Cardiology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28651249
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Butt+N%22">Butt N</searchLink>; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Bache-Mathiesen+LK%22">Bache-Mathiesen LK</searchLink><br /><searchLink fieldCode="AU" term="%22Nordrehaug+JE%22">Nordrehaug JE</searchLink><br /><searchLink fieldCode="AU" term="%22Tuseth+V%22">Tuseth V</searchLink><br /><searchLink fieldCode="AU" term="%22Munk+PS%22">Munk PS</searchLink><br /><searchLink fieldCode="AU" term="%22Bonarjee+V%22">Bonarjee V</searchLink><br /><searchLink fieldCode="AU" term="%22Hall+TS%22">Hall TS</searchLink><br /><searchLink fieldCode="AU" term="%22Jensen+SE%22">Jensen SE</searchLink><br /><searchLink fieldCode="AU" term="%22Halvorsen+S%22">Halvorsen S</searchLink><br /><searchLink fieldCode="AU" term="%22Firat+H%22">Firat H</searchLink><br /><searchLink fieldCode="AU" term="%22Atar+D%22">Atar D</searchLink><br /><searchLink fieldCode="AU" term="%22Larsen+AI%22">Larsen AI</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221266406%22">Cardiology</searchLink> [Cardiology] 2017; Vol. 138 (2), pp. 122-132. <i>Date of Electronic Publication: </i>2017 Jun 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>1266406 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1421-9751 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200086312%22">00086312 </searchLink><i>NLM ISO Abbreviation: </i>Cardiology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28651249
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000475460
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 122
    Titles:
      – TitleFull: Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Butt N
      – PersonEntity:
          Name:
            NameFull: Bache-Mathiesen LK
      – PersonEntity:
          Name:
            NameFull: Nordrehaug JE
      – PersonEntity:
          Name:
            NameFull: Tuseth V
      – PersonEntity:
          Name:
            NameFull: Munk PS
      – PersonEntity:
          Name:
            NameFull: Bonarjee V
      – PersonEntity:
          Name:
            NameFull: Hall TS
      – PersonEntity:
          Name:
            NameFull: Jensen SE
      – PersonEntity:
          Name:
            NameFull: Halvorsen S
      – PersonEntity:
          Name:
            NameFull: Firat H
      – PersonEntity:
          Name:
            NameFull: Atar D
      – PersonEntity:
          Name:
            NameFull: Larsen AI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1421-9751
          Numbering:
            – Type: volume
              Value: 138
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cardiology
              Type: main
ResultId 1